CARRYL MV 0.3MG/500MG/60MG TABLET
By Carryl MV
Rx
10 Tablet in a Strip

Composition
Voglibose(0.3mg) + Metformin(500mg) + Gliclazide(60mg)

Manufacturer - 4Care Lifescience Pvt Ltd
Nr. Parimal Under Bridge, C.G Road, Paldi, Ahmedabad, Gujarat – 380007

Expires on or after
August, 2025

liver
Claglid MV 0.3mg/500mg/60mg Tablet should be used carefully if you have liver disease. Your doctor may need to adjust the dose of Claglid MV 0.3mg/500mg/60mg Tablet. It is usually advised to start with a low dose in patients with mild to moderate liver disease. However, it is not recommended to use Claglid MV 0.3mg/500mg/60mg Tablet in patients with severe liver disease. Make sure to consult your doctor before using this medication if you have any liver issues.

kidney
Claglid MV 0.3mg/500mg/60mg Tablet should be used carefully in patients with kidney disease. Adjusting the dose may be necessary, and it is not advised for those with severe kidney issues. Regular monitoring of kidney function is recommended during treatment.

alcohol
Caution - Pregnancy Avoid alcohol when taking Claglid MV 0.3mg/500mg/60mg Tablet.

driving
When taking Claglid MV 0.3mg/500mg/60mg Tablet, avoid driving if experiencing low or high blood sugar symptoms, as it can affect focus and reaction time.

pregnancy
Claglid MV 0.3mg/500mg/60mg Tablet may not be safe during pregnancy. Studies in animals have shown potential harm to the baby. Your doctor will assess the benefits and risks before prescribing. Please consult your doctor before taking this medication during pregnancy.

breastfeeding
During breastfeeding, it is recommended to use Claglid MV 0.3mg/500mg/60mg Tablet with caution. It is advised to pause breastfeeding until the mother's treatment is finished and the medication is cleared from her system.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹140
Inclusive of all taxes
Content verified by

Dr. Monie Riju Simon
MBBS - General Medicine
Last update on 11-Feb-2025